Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. The VENTAK PRx Phase I Investigators.

@article{Porterfield1993ConversionRO,
  title={Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. The VENTAK PRx Phase I Investigators.},
  author={Jason Porterfield and Linda M. Porterfield and Bernadette A Smith and Lucy Bray and L Voshage and A. M. Mart{\'i}nez},
  journal={Pacing and clinical electrophysiology : PACE},
  year={1993},
  volume={16 1 Pt 2},
  pages={170-3}
}
Seventy consecutive patients received the first VENTAK PRx pulse generators (Cardiac Pacemakers, Inc.) implanted in the United States. This multiprogrammable device has therapeutic options that include: (1) antitachycardia pacing; (2) low energy cardioversion; (3) defibrillation shocks; and (4) bradycardia pacing. There were 60 males and 10 females with a mean age of 65.3 +/- 9.4 years. The anatomical diagnoses were coronary artery disease in 55 patients, cardiomyopathy in 7 patients… CONTINUE READING

Similar Papers

Loading similar papers…